#383Genetics & Molecular BiologyFront Page18 January 2026 Uveal Melanoma Prognosis: Charting a Genomic Trajectory
Researchers have identified a seven-gene molecular signature that accurately predicts survival outcomes and metastatic risk in uveal melanoma. By linking specific biomarkers to immune suppression, this study provides a validated framework for future targeted therapies.
By Shaanxi Eye Hospital, Xi’an People’s Hospital (Xi’an Fourth Hospital), Affiliated People’s Hospital of Northwest University, Xi’an 710004, Shaanxi Province, China, Guo, Wang, Shaanxi Eye Hospital, Xi’an People’s Hospital (Xi’an Fourth Hospital), Affiliated People’s Hospital of Northwest University, Xi’an 710004, Shaanxi Province, China, Huang, Shaanxi Eye Hospital, Xi’an People’s Hospital (Xi’an Fourth Hospital), Affiliated People’s Hospital of Northwest University, Xi’an 710004, Shaanxi Province, China, Wei, Shaanxi Eye Hospital, Xi’an People’s Hospital (Xi’an Fourth Hospital), Affiliated People’s Hospital of Northwest University, Xi’an 710004, Shaanxi Province, China, Han, Shaanxi Eye Hospital, Xi’an People’s Hospital (Xi’an Fourth Hospital), Affiliated People’s Hospital of Northwest University, Xi’an 710004, Shaanxi Province, China, Liu, People’s Hospital of Ningxia Hui Autonomous Region, Ningxia Medical University, Ningxia Clinical Research Institute, Yinchuan 750000, Ningxia Hui Autonomous Region, China, Ye, Shaanxi Eye Hospital, Xi’an People’s Hospital (Xi’an Fourth Hospital), Affiliated People’s Hospital of Northwest University, Xi’an 710004, Shaanxi Province, China